Stockreport

Plus Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement 

PLUS THERAPEUTICS, Inc.  (PSTV) 
PDF HOUSTON, April 21, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a healthcare company developing and commercializing precision diagn [Read more]